Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 6.9
(0.58%)
CNY 6.9
(0.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.22 Billion CNY | 1.36% |
| 2022 | 2.27 Billion CNY | 46.6% |
| 2021 | 1.55 Billion CNY | 3.51% |
| 2020 | 1.5 Billion CNY | 104.07% |
| 2019 | 735.94 Million CNY | 29.13% |
| 2018 | 569.93 Million CNY | -43.43% |
| 2017 | 1 Billion CNY | -48.29% |
| 2016 | 1.94 Billion CNY | 12.65% |
| 2015 | 1.72 Billion CNY | 188.5% |
| 2014 | 599.41 Million CNY | 258.08% |
| 2013 | 167.39 Million CNY | -35.72% |
| 2012 | 260.43 Million CNY | 10.87% |
| 2011 | 234.89 Million CNY | 8.01% |
| 2010 | 217.48 Million CNY | 36.48% |
| 2009 | 159.34 Million CNY | 27.27% |
| 2008 | 125.2 Million CNY | 24.66% |
| 2007 | 100.43 Million CNY | 68.62% |
| 2006 | 59.56 Million CNY | -3.51% |
| 2005 | 61.72 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 588.7 Million CNY | 12.83% |
| 2024 Q3 | 712.43 Million CNY | 23.43% |
| 2024 Q2 | 577.18 Million CNY | -1.96% |
| 2023 Q4 | 521.74 Million CNY | -20.61% |
| 2023 Q3 | 657.15 Million CNY | 6.65% |
| 2023 Q2 | 616.19 Million CNY | -26.84% |
| 2023 FY | 2.31 Billion CNY | 1.36% |
| 2023 Q1 | 842.27 Million CNY | 122.75% |
| 2022 Q2 | 619.24 Million CNY | -4.1% |
| 2022 FY | 2.27 Billion CNY | 46.6% |
| 2022 Q4 | 378.13 Million CNY | -40.54% |
| 2022 Q1 | 645.69 Million CNY | 1983.78% |
| 2022 Q3 | 635.91 Million CNY | 2.69% |
| 2021 FY | 1.55 Billion CNY | 3.51% |
| 2021 Q2 | 549.75 Million CNY | 15.17% |
| 2021 Q1 | 477.33 Million CNY | 97.37% |
| 2021 Q4 | -34.27 Million CNY | -106.1% |
| 2021 Q3 | 561.76 Million CNY | 2.18% |
| 2020 FY | 1.5 Billion CNY | 104.07% |
| 2020 Q4 | 241.85 Million CNY | -45.61% |
| 2020 Q1 | 376.82 Million CNY | 1871.91% |
| 2020 Q2 | 438.47 Million CNY | 16.36% |
| 2020 Q3 | 444.65 Million CNY | 1.41% |
| 2019 Q1 | 260.93 Million CNY | 213.83% |
| 2019 FY | 735.94 Million CNY | 29.13% |
| 2019 Q4 | 19.1 Million CNY | -91.67% |
| 2019 Q3 | 229.5 Million CNY | 1.38% |
| 2019 Q2 | 226.38 Million CNY | -13.24% |
| 2018 Q1 | -804.09 Million CNY | -726.42% |
| 2018 Q3 | -532.75 Million CNY | -187.34% |
| 2018 Q2 | -185.41 Million CNY | 76.94% |
| 2018 Q4 | -229.24 Million CNY | 56.97% |
| 2018 FY | 569.93 Million CNY | -43.43% |
| 2017 Q4 | -97.29 Million CNY | -134.55% |
| 2017 Q2 | 575.23 Million CNY | 131.98% |
| 2017 Q1 | 247.96 Million CNY | -45.57% |
| 2017 FY | 1 Billion CNY | -48.29% |
| 2017 Q3 | 281.58 Million CNY | -51.05% |
| 2016 Q2 | 418.24 Million CNY | 13.12% |
| 2016 Q3 | 704.62 Million CNY | 68.47% |
| 2016 Q4 | 455.57 Million CNY | -35.34% |
| 2016 FY | 1.94 Billion CNY | 12.65% |
| 2016 Q1 | 369.72 Million CNY | 10.61% |
| 2015 Q3 | 399.3 Million CNY | -26.45% |
| 2015 Q4 | 334.24 Million CNY | -16.29% |
| 2015 Q2 | 542.88 Million CNY | 19.87% |
| 2015 Q1 | 452.88 Million CNY | 100.96% |
| 2015 FY | 1.72 Billion CNY | 188.5% |
| 2014 Q1 | 77.68 Million CNY | 1599.28% |
| 2014 Q3 | 169.76 Million CNY | 34.1% |
| 2014 FY | 599.41 Million CNY | 258.08% |
| 2014 Q4 | 225.36 Million CNY | 32.75% |
| 2014 Q2 | 126.59 Million CNY | 62.96% |
| 2013 Q4 | -5.18 Million CNY | -107.17% |
| 2013 FY | 167.39 Million CNY | -35.72% |
| 2013 Q3 | 72.24 Million CNY | -2.31% |
| 2013 Q2 | 73.95 Million CNY | 180.34% |
| 2013 Q1 | 26.38 Million CNY | -73.02% |
| 2012 Q1 | 23.39 Million CNY | -67.29% |
| 2012 Q2 | 53.47 Million CNY | 128.59% |
| 2012 Q3 | 85.78 Million CNY | 60.43% |
| 2012 Q4 | 97.77 Million CNY | 13.98% |
| 2012 FY | 260.43 Million CNY | 10.87% |
| 2011 Q3 | 69.59 Million CNY | 3.03% |
| 2011 Q2 | 67.54 Million CNY | 157.33% |
| 2011 Q1 | 26.24 Million CNY | -63.18% |
| 2011 FY | 234.89 Million CNY | 8.01% |
| 2011 Q4 | 71.51 Million CNY | 2.76% |
| 2010 Q3 | 62.05 Million CNY | 10.1% |
| 2010 FY | 217.48 Million CNY | 36.48% |
| 2010 Q2 | 56.36 Million CNY | 102.98% |
| 2010 Q1 | 27.76 Million CNY | -54.17% |
| 2010 Q4 | 71.28 Million CNY | 14.87% |
| 2009 Q1 | 23.73 Million CNY | -0.4% |
| 2009 Q3 | 37.3 Million CNY | -1.09% |
| 2009 Q4 | 60.59 Million CNY | 62.42% |
| 2009 FY | 159.34 Million CNY | 27.27% |
| 2009 Q2 | 37.71 Million CNY | 58.92% |
| 2008 FY | 125.2 Million CNY | 24.66% |
| 2008 Q4 | 23.82 Million CNY | 4.87% |
| 2008 Q3 | 22.72 Million CNY | -43.49% |
| 2008 Q2 | 40.2 Million CNY | 4.59% |
| 2008 Q1 | 38.44 Million CNY | 32.9% |
| 2007 FY | 100.43 Million CNY | 68.62% |
| 2007 Q1 | 22.37 Million CNY | 0.0% |
| 2007 Q3 | 23.48 Million CNY | -8.4% |
| 2007 Q4 | 28.92 Million CNY | 23.17% |
| 2007 Q2 | 25.63 Million CNY | 14.56% |
| 2006 FY | 59.56 Million CNY | -3.51% |
| 2005 FY | 61.72 Million CNY | 0.0% |